𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of Time, Attendance of Medical Staff, and Resources During Radiotherapy for Head and Neck Cancer Patients

✍ Scribed by Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G. Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack

Publisher
Springer
Year
2011
Tongue
German
Weight
349 KB
Volume
187
Category
Article
ISSN
0179-7158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of glycoprotein constituents
Evaluation of glycoprotein constituents in head and neck cancer patients undergoing radiotherapy
✍ Rakesh M. Rawal; Prabhudas S. Patel; Beena P. Patel; Gira N. Raval; Mintoo M. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

Background. Alterations in serum levels of several glycoprotein constituents are reported to be useful for treatment monitoring of cancer patients. The purpose of this study was to determine efficacy of sialic acid and seromucoid fraction as treatment monitors for head and neck (H&N) cancer patients

Predictors of weight loss during radioth
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer
✍ Alice Nourissat; Isabelle Bairati; Elodie Samson; André Fortin; Michel Gélinas; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

## Abstract ## BACKGROUND: The purpose of the study was to identify predictors of weight loss during radiotherapy (RT) in patients with stage I or II head and neck (HN) cancer. ## METHODS: This study was conducted as part of a phase 3 chemoprevention trial. A total of 540 patients were randomize

Double blind randomized trial of sucralf
Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers
✍ Dennis L. Carter; Mary E. Hebert; Karen Smink; Kenneth A. Leopold; Robert L. Clo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Background. This study sought to determine whether sucralfate prophylaxis during a course of high dose radiation therapy (RT) for head and neck cancer decreases acute side effects. Methods. Patients receiving curative intent RT for advanced head and neck cancers participated in a single institution